Xiaojing Wang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
Papers in
- Hepatology 14
- Hepatitis C virus research 8
-
- Cancer, Hypoxia, and Metabolism 10
- Cancer-related molecular mechanisms research 7
Xiaojing Wang
105 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 141
- Cancer Research 664
- Immunology 616
- Hepatology 230
- Molecular Biology 1.3k
- Epidemiology 555
Countries citing papers authored by Xiaojing Wang
This map shows the geographic impact of Xiaojing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Wang more than expected).
Fields of papers citing papers by Xiaojing Wang
This network shows the impact of papers produced by Xiaojing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Wang. The network helps show where Xiaojing Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaojing Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 11 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 40 | |
| 10 | 2022 | 19 | |
| 11 | 2022 | 36 | |
| 12 | 2022 | 57 | |
| 13 | 2019 | 126 | |
| 14 | 2018 | 79 | |
| 15 | 2016 | 15 | |
| 16 | 2016 | 27 | |
| 17 | 2016 | 12 | |
| 18 | Determination of terramycin, minocycline and aureomycin in livestock, poultry meat and salmon by high performance liquid chromatography. | 2014 | 1 |
| 19 | Study on chemistry and pharmacology of glycyrrhiza polysaccharide | 2004 | 1 |
| 20 | 2004 | 176 |
About Xiaojing Wang
Xiaojing Wang is a scholar working on Hepatology, Cancer Research, Immunology, Neurology and Epidemiology, having authored 107 papers that have together received 2.9k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (18 papers), Hepatitis B Virus Studies (14 papers), Neuroblastoma Research and Treatments (13 papers), Cancer, Hypoxia, and Metabolism (10 papers), Hepatitis C virus research (8 papers), Cancer-related molecular mechanisms research (7 papers), Diabetes and associated disorders (6 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Cancer Research (664 citations), Immunology (616 citations), Hepatology (230 citations), Molecular Biology (1.3k citations) and Epidemiology (555 citations). Xiaojing Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Qin Ning, Kai Huang, Qiangsong Tong, Liduan Zheng, Allen G. Li, Xin‐Hua Feng, Donna Wang, Huajie Song, Erhu Fang and Yang Feng. Their work appears in journals such as Journal of Enzyme Inhibition and Medicinal Chemistry, Oncogene, Liver International, Hepatology International and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.